4/A//SEC Filing
GOLD DANIEL P PHD 4/A
Accession 0001209191-18-049972
CIK 0001262104other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 8:20 PM ET
Size
5.6 KB
Accession
0001209191-18-049972
Insider Transaction Report
Form 4/AAmended
MEI Pharma, Inc.MEIP
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
- Tax Payment
Common Stock
2018-08-06$3.75/sh−50,938$191,018→ 322,882 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018. The number of shares withheld by and surrendered to the Issuer was incorrectly reported as 54,093 in the original filing of the Form 4 to which this amendment relates. Such number of shares withheld was overstated by 3,155 shares.
- [F2]The number of shares beneficially owned was incorrectly understated by 3,155 shares in the original filing of the Form 4 to which this amendment relates as a result of the incorrect reporting of the number of shares withheld described in Note 1 above.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
Related Parties
1- filerCIK 0001288233
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 8:20 PM ET
- Size
- 5.6 KB